| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.06 |